Company / EPS (Basic)
Arcturus Therapeutics Holdings Inc. EPS (Basic) History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
-$1.12
FY2025
5-year range
-$7.74 / $0.35
FY2022-FY2025
Trend
-420.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
EPS (Basic) changed -420% YoY in FY2025, a notable deviation from the 3-year average annual change of -105%.
Based on SEC 10-K filings.
-1.12 in FY2025.
Improved from $-7.74 to $-1.12 over the past 2 years.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, eps (basic) decreased 420.0% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -0.06 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.12 | -420.0% |
| FY2024 | $0.35 | +104.5% |
| FY2023 | -$7.74 | +0.0% |
| FY2022 | -$7.74 | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026